Henan Taloph Pharmaceutical Stock Co.,Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 858.67 million compared to CNY 751.08 million a year ago. Revenue was CNY 863.68 million compared to CNY 751.87 million a year ago.

Net loss was CNY 25.43 million compared to net income of CNY 27.18 million a year ago. Basic loss per share from continuing operations was CNY 0.0452 compared to basic earnings per share from continuing operations of CNY 0.0485 a year ago. Diluted loss per share from continuing operations was CNY 0.0452 compared to diluted earnings per share from continuing operations of CNY 0.0485 a year ago.